Product Images Atorvastatin Calcium

This is a label of Atorvastatin Calcium 20mg tablets manufactured by NuCare Pharmaceuticals, Inc. It contains information such as lot number, expiration date, and National Drug Code (NDC) for the product. A warning is given to keep the medication out of reach of children and store it at a controlled temperature between 68-77°F. Consumers are advised to call their doctor for medical advice on any side effects and can report side effects to the FDA by calling 1-800-FDA-1088.*

The text appears to be a graph showing the cumulative incidence in percentage over the course of 35 years for two different treatments, Atorastatin and Placebo, with corresponding values given on the vertical axis from 0% to 40%. The horizontal axis displays the number of years. The graph indicates that Atorastatin has a lower cumulative incidence rate than Placebo over the course of 35 years, with an HR (hazard ratio) of 0.64 and a p-value of 0.00005.*

This is a graph showing the cumulative hazard percentage for a placebo and Atorvastatin. The hazard ratio for Atorvastatin compared to placebo is 0.63 with a confidence interval between 0.48 and 0.83 and a p-value of 0.001. It also shows the time to the first primary endpoint through four years of follow-up.*

This is a table presenting data on the percentage of subjects experiencing a major cardiovascular endpoint after taking atorvastatin at 10 mg or 80 mg. The data shows that the percentage of subjects experiencing the event was 0.2 for both doses, but a higher dose of 80 mg was associated with a lower hazard ratio (0.78) and a p-value of 0.0002. The table also shows the time to the first major cardiovascular endpoint over four years.*